Bound iron admixture prevents the spontaneous generation of peroxides in total parenteral nutrition solutions

Journal of Pediatric Gastroenterology and Nutrition

Volumn 25, Issue 3, 1997, Pages 307-311

  Lavoie, Jean Claude ^a   Chessex, Philippe ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Intravenous; Iron supplementation; Nutrition; Oxidation; Peroxides

Indexed keywords

CUMENE HYDROPEROXIDE; CYSTEINE; FERROUS CHLORIDE; FERROUS GLUCONATE; FERROUS SULFATE; FREE RADICAL; HYDROGEN PEROXIDE; IRON; IRON DEXTRAN; IRON SORBITEX; PEROXIDE; SCOPOLETIN; TERT BUTYL HYDROPEROXIDE; THIOL; TRANSFERRIN;

ARTICLE; COLORIMETRY; IRON THERAPY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION;

COLORIMETRY; FREE RADICALS; IRON; IRON-DEXTRAN COMPLEX; OXIDATION-REDUCTION; PARENTERAL NUTRITION, TOTAL; PEROXIDES; REACTIVE OXYGEN SPECIES; SCOPOLETIN; SOLUTIONS;

EID: 0030882226     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199709000-00011     Document Type: Article

References (39)

1. Lavoie JC, Chessex P. Admixture of a multivitamin preparation to parenteral nutrition: the major contributor to in vitro generation of peroxides. Pediatrics 1997;99:1-5.
2. Lunec J. Free radicals: Their involvement in disease process. Ann Clin Biochem 1990;27:172-82.
3. Van der Zee J, Krootjes BBH, Chignell CF, Dubbelman TMAR, VanSteveninck J. Hydroxyl radical generation by a light dependent Fenton reaction. Free Radic Biol Med 1993;14:105-13.
4. Warner BB, Wispé JR. Free radical-mediated diseases in pediatrics. Semin Perinatal 1992;16:47-57.
5. Fleming CC. Trace element metabolism in adult patients requiring total parenteral nutrition. Am J Clin Nutr 1989;49:573-9.
6. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi, et al. The effect of epoetin (recombinant human erythropoietin) on the need for transfusion m very-low-birth-weight infants. New Engl J Med 1994;330:1173-8.
7. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subject. Blood 1993;81:956-64.
8. Kooistra MP, Van Es SA, Struyvenberg A, Marx JJM. Iron metabolism in patients with anemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol 1991;79:634-9.
9. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121: 98-102.
10. Friel JK, Penney S, Reid DW, Andrews WL. Zinc, copper, manganese, and iron balance of parenterally fed very low birth weight preterm infants receiving a trace element supplement. JPEN 1988; 12:382-6.
11. Ben Hariz MB, Goulet O, De Potter O, Girot R, Rambaud C, Colomb V, et al. Iron overload in children receiving prolonged parenteral nutrition. J Pediatr 1993;123:238-41.
12. Sayers MH, Johnson DK, Schuman LA, Ivey MF, Young JH, Finch CA. Supplementation of total parenteral nutrition solutions with ferrous citrate. JPEN 1983;7:117-20.
13. Norton JA, Peters ML, Wesley R, Maher MM, Brennan MF. Iron supplementation of total parenteral nutrition: a prospective study. JPEN 1983;7:457-61.
14. Gokal R, Millard PR, Weatherhall DJ. Iron metabolism in heamodialysis patients. Quarterly Journal of Medicine 1979;191:369-91.
15. Weinberg ED. Iron withholding: a defense against infection and neoplasia. Physiol Rev 1984;64:65-107.
16. Walter T, Olivares M, Pizarro F. Iron and infection. In: Filer LJ, Jr, Ed. Dietary iron: birth to two years. New York: Raven Press Ltd, 1989:119-39.
17. Barry D, Reeve AW. Increased incidence gram-negative neonatal sepsis with intramuscular iron administration. Pediatrics 1977;60: 908-12.
18. Oppenheimer SJ, MacFarlane SBJ, Moody JB, Bunari O, Hendrickage RG. Effect of iron prophylaxis on morbidity due to infectious disease. Trans R Soc Trop Med Hyg 1986;80:596-602.
19. Danielson BG, Geisser P, Schneider W, eds. Iron therapy with special emphasis on intravenous administration. Switzerland: Vitor Inc. 1996:1-67.
20. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids 1991;26:853-6.
21. Lavoie JC, Lachance C, Chessex P. Antiperoxyde activity of sodium metabisulfite: a double-edged sword. Biochem Pharmacol 1994;47:871-6.
22. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
23. Brawley V, Bhatia J, Karp WB. Hydrogen peroxide generation in a model pediatric parenteral amino acid solution. Clin Sci 1993; 85:709-12.
24. Vaughan LM, Small C, Plunkett V. Incompatibility of iron dextran and a total nutrient admixture. Am J Hosp Pharm 1990;47:1745-6.
25. Tu YH, Knox NL, Biringer JM, Eichman ML, Schweinsberg PD, Howard JR. Compatibility of iron dextran with total nutrient admixtures. Am J Hosp Pharm 1992;49:2233-5.
26. Wan KK, Tsallas G. Dilute iron dextran formulation for addition to parenteral nutrient solutions. Am J Hosp Pharm 1980;37:206-10.
27. Ali M, Kasper V. Efficacy of iron dextran in parenteral nutrient solutions. Am J Hosp Pharm 1985;42:784-6.
28. Wood JK, Milner PFA, Pathak UN. The metabolism of iron-dextran given as a total dose infusion to iron deficient Jamaican subjects. Br J Haematol 1968;14:119-29.
29. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. JAMA 1980;243:1726-31.
30. Friel JK, Andrews WL, Hall SM, Rodway MS, Keith M, McCloy UC, Matthew D, Long DR. Intravenous iron admixture to very-low-birth-weight newborns receiving total and partial parenteral nutrition. JPEN 1995;19:114-8.
31. Barat AC, Harrie K, Jacob M, Diamantis TG, McIntosh NL. Effect of amino acid solutions on total nutrient admixture stability. JPEN 1987;11:384-8.
32. Pitkanen O, Hallman M, Anderson S. Generation of free radicals in lipid emulsion used in parenteral nutrition. Pediatr Res 1991;29:56-9.
33. Miebert LM, Lui J. Dextran sulfates protect porcine arterial endothelial cells from free radical injury. Hum Exp Toxicol 1994;13: 233-9.
34. American College of Physicians. Oxygen radicals and human disease. Ann Intern Med 1987;107:526-45.
35. Moison RMW, Palinck JJS, Roset M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993;341:79-82.
36. Galet S, Schulman HM, Bard H. The postnatal hypotransferrinemia of early preterm newborn infants. Pediatr Res 1976;10: 118-20.
37. Saarinen UM, Siimes MA. Developmental changes in serum iron, total iron-binding capacity, and transferrin saturation in infancy. J Pediatr 1977;91:875-7.
38. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Letters 1994;349:197-200.
39. Widness JA, Hayn M, Pollak A, Schmidt RL, Lambert DJ, Lubec G. Oxygen free radical damage in neonatal lambs treated with iv iron. Pediatr Res 1996;39:293A.